When the effects of COVID-19 took root in the US, a shift away from typical routines was triggered, one which brought far reaching repercussions. In all areas of life, this pandemic has forced change, no matter the feasibility of adapting to such change. Where clinical trials are concerned, the adjustment has proven difficult, while also shining light on a new era of opportunity.
The creation and implementation of new guidelines to ensure the safety and integrity of trials by the FDA will undoubtably take time, leaving a level of uncertainty surrounding which new and innovative protocols for executing trials will be deemed acceptable. One thing that remains paramount is prioritizing the safety of patients, and to the highest possible degree, ensuring trial integrity. The assurance of these key facets of clinical trials hinges largely upon regulatory compliance.
Prior to the outbreak of COVID-19, there was a clear shift towards patient-centric medicine. Virtual tools assisting patients in all areas of medical care were growing more and more popular. However, the adoption of these tools for use in clinical trials had been slow to ramp up due to deeply ingrained, conservative processes. Yet now, innovative technologies are the only viable solution capable of navigating clinical trials through this arduous time, and there is no time to wait. While the infrastructure in place to support this transition is severely lacking, COVID-19 is forcing the adoption of these new processes, and the industry will have to find a way to catch up.
The potential for technological innovation to improve clinical trials is immense, ranging from research and development, patient testing, regulatory affairs and more. Now more than ever, companies will have to adjust their processes to integrate new technological solutions, and when it comes to finding a partner, those with trusted, innovative solutions will truly stand out. In the realm of regulatory affairs, MVG has proven itself to be that partner, and is motivated to continue helping companies to uphold their regulatory standard as they navigate the changing landscape.
MVG Consulting Services specializes in helping small to medium sized biotechnology and pharmaceutical companies with their clinical development programs and we can provide start-up and virtual companies with the necessary resources to begin their clinical development program.
Services include:
- Clinical Research Consulting Services
- Clinical Trial Development
- Project Rescue
- Inspection Readiness
MVG provides highly qualified clinical research professionals who seamlessly become a part of your project team. Additionally, we provide virtual companies with an entire project team that encompasses all aspects of clinical development.
We invite you to fill out the form below to learn more about how MVG Consulting can help you with your clinical devleopment needs.
